Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: Randomised controlled trial

BMJ

Volumn 342, Issue 7808, 2011, Pages

  Vadillo Ortega, Felipe ^a   Perichart Perera, Otilia ^b   Espino, Salvador ^b   Avila Vergara, Marco Antonio ^c   Ibarra, Isabel ^d   Ahued, Roberto ^b   Godines, Myrna ^a   Parry, Samuel ^e   Macones, George ^e,f   Yanow, Mitchell ^e,f   Yanow, Elaine ^e,f   Strauss, Jerome F ^g  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGININE; PLACEBO; VITAMIN;

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD COMPOSITION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK REDUCTION; TERTIARY HEALTH CARE; ADULT; FOOD; HIGH RISK PREGNANCY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE;

ADULT; ANTIOXIDANTS; ARGININE; DIETARY SUPPLEMENTS; FEMALE; FOOD; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL CARE; VITAMINS;

EID: 79957622596     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2901     Document Type: Article

References (47)

1. Ronsmans C, Graham W. Maternal mortality: who, when, where, and why. Lancet 2006;368:1189-200.
2. Meher S, Duley L. Interventions for preventing pre-eclampsia and its consequences: generic protocol. Cochrane Database Syst Rev 2005;2:CD005301.
3. Mignini LE, Villar J, Khan KS. Mapping the theories of pre-eclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 2006;194:317-21. (Pubitemid 43183678)
4. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-99.
5. Davidge S. Oxidative stress and altered endothelial cell function in pre-eclampsia. Semin Reprod Endocrinol 1998;16:65-73. (Pubitemid 28285305)
6. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A 1989;86:3375-8. (Pubitemid 19129614)
7. Morris N, Eaton BM. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1996;103:4-15. (Pubitemid 26011409)
8. Visek WJ. Arginine needs, physiological state and usual diets: a reevaluation. J Nutr 1986;116:36-46. (Pubitemid 16212053)
9. Conrad KP, Joffe GM, Kruszyna H, Kruszina R, Rochelle LG, Smith RP, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993;7:566-71. (Pubitemid 23120904)
10. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimetylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003;361:1511-7. (Pubitemid 36566342)
11. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1)may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58. (Pubitemid 36278583)
12. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of pre-eclampsia. Nature Med 2006;12:642-9. (Pubitemid 43865232)
13. Fraser, R. Pre-eclampsia and diet. In: Strain JJ, Caballero B, Sadler MJ, eds The encyclopedia of human nutrition. Academic Press, 1998:1620-6.
14. Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, et al. Effects of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 1992;33:41-8.
15. Campese VM, Amar M, Anjali C, Medhat T, Wurgraft A. Effects of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension. J Hum Hypertens 1997;11:527-32. (Pubitemid 27434782)
16. Rosano GMC, Panina G, Cerquetani E, Leonardo F, Pelliccia F, Bonfigli B, et al. L-arginine improves endothelial function in newly diagnosed hypertensives. J Am Coll Cardiol 1998;31:262A.
17. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
18. Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997;129:261-9. (Pubitemid 27135328)
19. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, et al. Randomized, double-blind placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:2135-41.
20. Bode-Boger SM, Boger RH, Galland A, Tsikas D, Frolich JC. L-arginine-induced vasodilatation in healthy humans: pharmacokinetic pharmacodynamic relationship. Br J Clin Pharmacol 1998;46:489-97. (Pubitemid 28484737)
21. Facchinetti F, Neri I, Genazzani AR. L-arginine infusion reduces preterm uterine contractions. J Perinat Med 1996;24:383-5.
22. Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F. Effects of Larginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand 1996;75:208-12. (Pubitemid 26105273)
23. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;2:CD006490.
24. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in pre-eclampsia, are positively correlated and decrease within 48 hours post partum. Am J Obstet Gynecol 1996;174:975-82. (Pubitemid 26111679)
25. Barden A, Beilin LJ, Ritchie J, Croft KD, Walters BN, Michael CA. Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci 1996;91:711-8. (Pubitemid 26413825)
26. Sagol S, Ozkinay E, Ozsener S. Impaired antioxidant activity in women with pre-eclampsia. Int J Obstet Gynecol 1999;64:121-7. (Pubitemid 29096268)
27. Stratta P, Canavese C, Porcu M, Dogliani M, Todros T, Garbo E, et al. Vitamin E supplementation in pre-eclampsia. Gynecol Obstet Invest 1994;37:246-9.
28. Gulmezoglu AM, Hofmeyr GJ, Oosthuizen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997;104:689-96.
29. Chappell L, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999;354:810-6. (Pubitemid 29415585)
30. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008;1:CD004227.
31. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362:1282-91.
32. Papapetropoulos A, Garcia-Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997;100:3131-9. (Pubitemid 28022851)
33. Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med 2000;5:11-9. (Pubitemid 30143357)
34. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-61.
35. Orsonneau J, Douet P, Massoubre C, Lustenberger P, Bernard S. An improved pirogallol re-molybdate method for determining total urine protein. Clin Chem 1989;35:2233-6. (Pubitemid 20004702)
36. Lundsjo A, Hagelberg S, Palmer K, Lindblad BS. Amino acid profiles by HPLC after filter paper sampling: "appropriate technology" for monitoring of nutritional status. Clin Chim Acta 1990;191:201-10.
37. Levine M, Walter S, Lee H, Haines T, Holbrook A, Pharm D, et al. User's guides to the medical literature. IV: how to use an article about harm. JAMA 1994;271:1615-9.
38. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559. (Pubitemid 28207702)
39. Banerjee S, Chambers A, Campbell S. Is vitamin E a safe prophylaxis for pre-eclampsia? Am J Obstet Gynecol 2006;194:1228-33.
40. Hnat MD, Sibai BM, Caritis S, Hauht J, Lindheimer MD, MacPherson C, et al. Perinatal outcome in women with recurrent pre-eclampsia compared with women who develop pre-eclampsia as nulliparas Am J Obstet Gynecol 2002;186,422-6.
41. Hjartardottir S, Leifsson B, Geirsson R, Steinhorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol 2006;194:916-20.
42. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem1994;269:26066-75.
43. Facchinetti F, Longo M, Piccinni F, Neri I, Volpe A. L-arginine infusion reduces blood pressure in pre-eclamptic women through nitric oxide release. J Soc Gynecol Investig 1999;4:202-7. (Pubitemid 29408664)
44. Staff AC, Berge L, Haugen G, Lorenzen B, Mikkelsen B, Henriksen T. Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 2004;83:103-7. (Pubitemid 38121737)
45. Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in pre-eclampsia. Eur J Clin Invest 2005;35:32-7. (Pubitemid 40187952)
46. Germain AM, Valdez G, Romanik MC, Reyes S. Letter to the editor: evidence supporting a beneficial role for long term L-arginine supplementation in high-risk pregnancies. Hypertension 2004;44:e1.
47. Neri I, Monari F, Sgarbi L, Berardi A, Masellis G, Facchinetti F. L-arginine supplementation in women with chronic hypertension: impact on blood pressure andmaternal and neonatal complications. J Matern Fetal Neonatal Med 2010;23:1456-60.